Genus plc (LON:GNS)
2,104.00
+30.00 (1.45%)
Sep 25, 2026, 1:23 PM GMT
Genus Employees
Genus had 3,190 employees as of June 30, 2025. The number of employees decreased by 310 or -8.86% compared to the previous year.
Employees
3,190
Change (1Y)
-310
Growth (1Y)
-8.86%
Revenue / Employee
206.30K GBP
Profits / Employee
89.44K GBP
Market Cap
1.39B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,190 | -310 | -8.86% |
| Jun 30, 2024 | 3,500 | 0 | - |
| Jun 30, 2023 | 3,500 | 0 | - |
| Jun 30, 2022 | 3,500 | 100 | 2.94% |
| Jun 30, 2021 | 3,400 | 300 | 9.68% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oxford Nanopore Technologies | 1,314 |
| Oxford Biomedica | 977 |
| 4basebio | 140 |
| PureTech Health | 90 |
| Avacta Group | 81 |
| Scancell Holdings | 60 |
| Faron Pharmaceuticals Oy | 36 |
| Poolbeg Pharma | 15 |
Genus News
- 15 days ago - Genus H2 Earnings Call Highlights - MarketBeat
- 15 days ago - Genus Earnings Call Transcript: H2 2026 - Transcripts
- 15 days ago - Genus Annual report: H2 2026 - Filings
- 15 days ago - Genus Slides: H2 2026 - Filings
- 4 weeks ago - GNS Looks 157.1% Overvalued on GF Value™ - GuruFocus
- 7 weeks ago - Genus upgraded to Buy from Hold at Kepler Cheuvreux - TheFly
- 2 months ago - Genus Earnings release: Trading update - Filings
- 4 months ago - Genus initiated with an Overweight at JPMorgan - TheFly